Health officials have launched clinical trials to evaluate treatments and preventive drugs for the Bundibugyo strain of the Ebola virus. The studies target both active infections and post-exposure prophylaxis to combat the ongoing outbreak.

Confirmed Ebola cases in the Democratic Republic of the Congo have reached 1,502, creating a public health crisis across the nation's eastern provinces. Medical authorities face significant containment hurdles as the virus spreads through areas affected by conflict.